Personalis, Inc. · 2 days ago
Director, Sales Training
Personalis is transforming cancer management through personalized testing. As the Director of Sales Training, you will ensure the sales organization is equipped with clinical data and strategies to excel in complex sales situations.
BiotechnologyGeneticsHealth CareHealth Diagnostics
Responsibilities
Design and execute a world-class "New Hire Excellence" program that reduces ramp-up time for Territory Managers
Develop a curriculum covering the Personalis value proposition, the clinical utility of our assays, and the competitive landscape
Implement ongoing training for the sales team, focusing on clinical messaging, objection handling, and account management
Partner with the Medical Science Liaison (MSL) team to synthesize complex clinical data into "sales-ready" messaging
Establish and lead a regular cadence for presenting competitive intelligence, ensuring the sales team is prepared to pivot against market shifts and competitor claims
Distill technical white papers and trial results into high-impact talk tracks and sales tools
Manage the training tech stack (e.g., LMS, Sales Enablement platforms) to track completion and competency metrics
Collaborate with Marketing to ensure all sales collateral is integrated into training modules and used effectively in the field
Qualification
Required
A Bachelor's degree in Marketing, Communications, or the Life Sciences is required
10+ years in Sales Training or Sales Enablement within the Diagnostics, Biotech, or Medical Device sectors (Oncology experience highly preferred)
Ability to 'speak the language' of MSLs and Oncologists while translating that knowledge into a commercial context
Proven track record of leading training initiatives that directly resulted in increased quota attainment
Exceptional presentation skills
Preferred
Oncology experience highly preferred
Benefits
Medical
Dental
Vision
401(k) match
ESPP
Tuition reimbursement
Sick/vacation time
Commuter benefits/ EV charging stations
Onsite gym
Wellness benefits
Company
Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing.
Funding
Current Stage
Public CompanyTotal Funding
$311.25MKey Investors
MerckTempusLightspeed Venture Partners
2024-12-19Post Ipo Equity· $50M
2024-08-16Post Ipo Equity· $36.15M
2021-01-27Post Ipo Equity· $150.1M
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase